🔎 Trials Near Me

Hjem › Lungecancer › Iowa

Lungecancer kliniske forsøg i Iowa

19 studier for Lungecancer søger deltagere på steder i Iowa.

Byer i Iowa

Officiel studietekst (engelsk)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • og 14 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • og 12 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
  • og 7 flere
RekruttererFase 3
Alder 70 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • og 10 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • og 11 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • University of Iowa Health Care Cancer Services Quad Cities, Bettendorf
  • University of Iowa Hospitals & Clinics, Iowa City
  • University of Iowa Health Care, Mission Cancer + Blood, Waukee
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT06881784

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • Local Institution - 0065, Iowa City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06618287

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • Physicians Clinic of Iowa, Cedar Rapids
  • Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06712316

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • McFarland Clinic, Ames
  • Helen G. Nassif Community Cancer Center, Cedar Rapids
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • og 12 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT05624996

Integrated Cancer Repository for Cancer Research

  • Methodist Jennie Edmundson Hospital, Council Bluffs
  • Covenant Medical Center, Inc, Waterloo
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699

CHAMP Lung Cancer Screening Program

  • University of Iowa, Iowa City
  • Cedar Valley Primary Care & Walk-In Clinic, Waterloo
  • Greenwood Pharmacy and Compounding Center, Waterloo
Rekrutterer
Alder 50 til 77 · Alle køn · Opdateret 16. jun. 2026 · NCT07572773

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive
  • Iowa Methodist Medical Center, Des Moines
  • og 4 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 3. jun. 2026 · NCT05642572

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

  • University of Iowa Health Care, Iowa City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 14. maj 2026 · NCT06922591

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • og 7 flere
RekruttererFase 2
18 Minutes · Alle køn · Opdateret 5. maj 2026 · NCT06031688

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

  • University of Iowa Hospitals and Clinics, Iowa City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 8. apr. 2026 · NCT04919382

Using Xe MRI to Guide Radiation Therapy for Lung Cancer

  • University of Iowa, Iowa City
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 2. jan. 2026 · NCT06925295

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Iowa City
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.